We are your trusted health partner. Local doorstep deliveries is within the hour .We are Licensed and Regulated by the Pharmacist's Council of Nigeria(PCN).Prices displayed here may differ due to inflation.
A premium, clinically validated recombinant DNA-derived humanized monoclonal antibody administered via subcutaneous (SC) injection. It functions systemically as a targeted biological therapy to manage severe, persistent allergic asthma and chronic spontaneous urticaria.
Omalizumab 150mg is a biological drug designed to interrupt the allergic cascade at its earliest stage. Unlike traditional medications that treat allergy symptoms after they appear, this monoclonal antibody targets the root cause of the allergic response.
Once injected into the subcutaneous tissue, it clears allergic inflammation through a highly specific cellular mechanism:
IgE Binding and Neutralization: It binds selectively to circulating Human Immunoglobulin E ($\text{IgE}$) in the blood and tissue fluids, forming stable complexes. This physically blocks $\text{IgE}$ from attaching to the high-affinity $\text{Fc}\epsilon\text{RI}$ receptors on the surfaces of mast cells and basophils.
Downregulation of Receptors: By keeping free $\text{IgE}$ levels exceptionally low, it prompts cells to naturally reduce (downregulate) the number of $\text{IgE}$ receptors on their surfaces over time.
Suppression of Inflammatory Release: Because the $\text{IgE}$ cannot bind to mast cells, allergen exposure fails to trigger the release of dangerous chemical mediators like histamine, leukotrienes, and cytokines. This stops the swelling of your airways and prevents hives from breaking out on your skin.
Severe Allergic Asthma: An add-on maintenance treatment for adults and pediatric patients (6 years of age and older) with moderate-to-severe persistent asthma who have a positive skin test or blood test to year-round airborne allergens, and whose symptoms are inadequately controlled by high-dose inhaled corticosteroids.
Chronic Spontaneous Urticaria (CSU): Treating chronic, unprovoked hives and severe skin swelling (angioedema) in adults and adolescents (12 years of age and older) who continue to experience symptoms despite taking high-dose H1-antihistamine therapies.
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): An add-on maintenance therapy in adults whose nasal polyps are not adequately managed by nasal corticosteroids.
Subcutaneous (SC) Injection Only: Omalizumab is administered strictly as a subcutaneous injection into the fleshy tissue of the deltoid region of the upper arm, the thigh, or the abdomen.
Note: It must never be injected intravenously (IV) or intramuscularly (IM). Because it is a thick biological fluid, a single 150mg dose must be injected slowly over 5 to 10 seconds to minimize localized discomfort.
Adults and eligible pediatric populations who have undergone thorough blood tracking to measure their baseline Total Serum $\text{IgE}$ levels and body weight, which are used to calculate their exact customized dose and injection schedule (either every 2 or every 4 weeks).
Acute Asthma Attacks: Strictly contraindicated for treating sudden, severe asthma flare-ups. Omalizumab is not a rescue medication and will not widen your airways during an acute attack. Always keep a fast-acting inhaler (like salbutamol) on hand for emergency use.
Severe Monoclonal Antibody Hypersensitivity: Do not use if you have a known history of severe systemic allergic reactions or anaphylaxis to omalizumab or any of the structural components inside the vial.
The Anaphylaxis Vigilance Rule: In rare cases, this biological drug can trigger a severe, life-threatening allergic reaction (Anaphylaxis) shortly after injection, or sometimes days later. Because of this risk, your healthcare provider will monitor you closely in a clinic setting for 1 to 2 hours after your first few injections.
The Continuity Mandate: You must not stop or alter your regular doses of other asthma or allergy medications (especially oral or inhaled steroids) when starting omalizumab. This treatment is a long-term maintenance therapy; its benefits develop gradually over several weeks.
The Reconstitution Guideline: If using the lyophilized powder presentation, it must be dissolved strictly using the provided sterile water for injection. It can take up to 20 minutes of gentle swirling (never shaking) for the thick powder to dissolve completely into a clear, slightly pale-yellow solution.
1.Verify the patient's weight and baseline IgE metrics:Dose Calibration.
Confirm that the patient's customized dosing matrix has been calculated correctly using their recent body weight and baseline serum $\text{IgE}$ lab scores before preparing the injection.
2.Bring the vial to room temperature and dissolve gently:Preparation.
Remove the vial from the refrigerator. Reconstitute the powder slowly, swirling the vial gently every few minutes. Inspect the fluid to ensure it is completely clear and free of solid particles before drawing it into the syringe.
3.Inject slowly into the subcutaneous tissue layer:Subcutaneous Delivery.
Cleanse the selected skin site (such as the thigh or upper arm). Pinch the skin fold firmly and insert the needle at a 45 to 90-degree angle, pushing the plunger down slowly over 5 to 10 seconds.
4.Monitor the patient closely for post-injection safety:Clinical Observation.
Keep the patient resting comfortably in your clinic waiting area for at least 30 to 60 minutes. Check for signs of sudden breathing distress, body-wide itching, or swelling of the face and throat.
By systemically altering your immune response pathways and introducing a foreign protein matrix, this biological injection can prompt temporary adjustments, including:
Localized pain, mild swelling, itching, bruising, or skin redness directly around the subcutaneous needle insertion site.
General systemic shifts, including mild-to-moderate headaches, joint pain (arthralgia), muscle fatigue, or dizziness.
Pediatric-specific updates, including a temporary increase in upper abdominal pain, bloating, nausea, or mild fevers in young children.
Serious Risk Warning: A delayed systemic allergic response or anaphylaxis marked by throat tightening, wheezing, hives, and low blood pressure can occur. Seek emergency medical care immediately if these symptoms appear.
How long does it take for Omalizumab 150mg to start controlling my asthma or hives?
Because this is a biological therapy that works by gradually lowering free $\text{IgE}$ levels and reducing cell receptors, it does not provide instant relief. Most patients begin to see a noticeable decrease in asthma flare-ups or hives within 12 to 16 weeks of continuous, scheduled therapy.
Does this injection need to be stored in a refrigerator?
Yes, absolutely. Omalizumab is a delicate biological protein that must be stored securely inside a medical refrigerator at a temperature between $2^\circ\text{C}$ and $8^\circ\text{C}$. It must never be frozen or exposed to intense direct sunlight, as extreme temperatures destroy the protein structure and make the medicine useless.
Can I learn to self-inject Omalizumab 150mg at home?
Self-injection at home using a pre-filled syringe or autoinjector may be considered appropriate only after your doctor confirms you are a good candidate, you have shown no signs of anaphylaxis during initial clinic treatments, and you have been fully trained on proper technique and recognizing delayed allergic reactions.
You can purchase authentic, factory-sealed Omalizumab for Injection 150mg vials online through Sanlive Pharmacy & Stores for secure payment and fast, reliable same-day delivery directly to your designated hospital, clinic, or home within Lagos, Abuja, and Port Harcourt.
Important Notice: This information is for educational support and tracking purposes only. Omalizumab is a high-potency, specialized biological therapy that must be calibrated, prepped, and monitored strictly under the direct guidance and diagnostic supervision of a certified pulmonologist, allergist, or medical professional.
No reviews yet — be the first!
Log in to write a review.
.jpg)
